Answer:
No – the press release that was summarized does not contain any forward‑looking guidance from Limb‑Lach’s management for the third quarter of 2025 (Q3 2025) or for the full‑year 2025.
The excerpt only provides historical operating results for the quarter ended June 30 2025 (revenue, net income, adjusted net income, etc.) and does not include any statements such as “We expect Q3 2025 revenue to be …” or “We anticipate full‑year 2025 earnings of ….” Therefore, based on the information provided, management has not disclosed guidance for either Q3 2025 or the full‑year 2025 in this release.
Other Questions About This News
How did gross margin and operating margin change compared to Q2 2024?
What is the company's free cash flow for the quarter and how does it compare to prior periods?
Is the increase in net income and adjusted EPS being driven by volume growth, pricing power, or cost reductions?
What were the primary drivers behind the 16.4% revenue increase year-over-year?
How does the EPS growth compare with analyst consensus and expectations?
What is the current debt level and any changes in leverage ratios?
What are the expected impacts of any macroeconomic or industry trends on future earnings?
What is the outlook for capital expenditures and potential impact on cash flow?
What is the current valuation multiple (e.g., P/E, EV/EBITDA) after this earnings release and how does it compare to peers?
How does the company's revenue growth compare to key competitors in the same market segment?
Are there any specific one-time items or non-recurring expenses affecting the reported net income?
Is there any change in management commentary on market positioning or product pipeline?
Did the company return any capital to shareholders via dividends or share repurchases during the quarter?
How does the adjusted net income figure compare to GAAP net income, and what adjustments were made?